Therapeutic potential of novel selective-spectrum kinase inhibitors in oncology
Author:
Affiliation:
1. Barbara Ann Karmanos Cancer Institute/ Wayne State University, Hudson-Webber
2. Clinical Research Discovery Medicine Oncology, AstraZeneca LP, 35 Gatehouse Drive, Waltham, MA 02451, USA ; ;
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/13543784.17.7.1013
Reference108 articles.
1. Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer
2. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST)
3. The Concept of Synthetic Lethality in the Context of Anticancer Therapy
4. The DNA damage response: putting checkpoints in perspective
5. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Principles of Dose, Schedule, and Combination Therapy;Holland‐Frei Cancer Medicine;2022-10-21
2. A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data;Frontiers in Pharmacology;2022-06-29
3. Principles of Dose, Schedule, and Combination Therapy;Holland‐Frei Cancer Medicine;2019-12-06
4. Sunitinib in the Treatment of Thyroid Cancer;Current Medicinal Chemistry;2019-05-13
5. Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the A rt and New Perspectives with Patents Recently Applied;Recent Patents on Anti-Cancer Drug Discovery;2018-05-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3